EQRx
Biotechnology ResearchMassachusetts, United States201-500 Employees
Effective 11/09/23, EQRx., Inc. is now a wholly-owned subsidiary of Revolution Medicines (https://www.revmed.com/)
Insights
Strategic Acquisition Impact EQRx's recent acquisition of CM Life Sciences III Inc. has opened up sales opportunities due to potential synergies and expanded capabilities.
Revenue Growth Potential EQRx's revenue in the range of $10M - $50M indicates a solid financial position, suggesting capacity for larger purchases and partnerships.
Investor Interest Investor alert investigations and positive earnings estimates around EQRx could attract new stakeholders, potentially increasing commercial opportunities.
Tech Stack Utilization By utilizing a diverse tech stack including TensorFlow and Python, EQRx demonstrates a commitment to innovation that can be leveraged in client pitches.
Competitive Benchmarking Comparing employee headcount and revenue with similar companies like Kymera Therapeutics and Relay Therapeutics can provide insights into market positioning and potential growth areas.
Similar companies to EQRx
Skyhawk Therapeutics
$10M$50MKronos Bio
$10M$50MCorvidia Therapeutics
Syros Pharmaceuticals
$10M$50MKymera Therapeutics
$10M$50MFlagship Pioneering
$50M$100MRheos Medicines
Omega Therapeutics
$10M$50MGoldfinch Bio
$10MRelay Therapeutics
$10M$50MTango Therapeutics
$10M$50MCelsius Therapeutics
$10M
EQRx Tech Stack
EQRx uses 8 technology products and services including jsDelivr, ADP, Slick, and more. Explore EQRx's tech stack below.
- jsDelivrContent Delivery Network
- ADPHuman Resource Management System
- SlickJavascript Libraries
- jQueryJavascript Libraries
- TensorFlowMachine Learning
- PythonProgramming Languages
- JavaScriptProgramming Languages
- PerlProgramming Languages
Media & News
EQRx's Email Address Formats
EQRx uses at least 2 format(s):
| EQRx Email Formats | Percentage |
| FLast@eqrx.com | 94% |
| Last@eqrx.com | 4% |
| FMiddleLast@eqrx.com | 1% |
| FL@eqrx.com | 1% |
| FLast@revmed.com | 77% |
| First@revmed.com | 22% |
| Last@revmed.com | 1% |
Frequently Asked Questions
Where is EQRx's headquarters located?
EQRx's main headquarters is located at Cambridge, MA US. The company has employees across 4 continents, including North AmericaEuropeSouth America. What is EQRx's stock symbol?
EQRx is a publicly traded company; the company's stock symbol is EQRX. What is EQRx's official website and social media links?
EQRx's official website is revmed.com and has social profiles on LinkedIn.How much revenue does EQRx generate?
As of December 2023, EQRx's annual revenue reached $35M. What is EQRx's SIC code NAICS code?
EQRx's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).How many employees does EQRx have currently?
As of December 2023, EQRx has approximately 201 employees across 4 continents, including North AmericaEuropeSouth America. Key team members include Chief Executive Officer: M. N.Chief Compliance And Risk Officer: C. C.Chief Financial Officer: J. R.. Explore EQRx's employee directory with LeadIQ.What industry does EQRx belong to?
EQRx operates in the Biotechnology Research industry. What technology does EQRx use?
EQRx's tech stack includes jsDelivrADPSlickjQueryTensorFlowPythonJavaScriptPerl. What is EQRx's email format?
EQRx's email format typically follows the pattern of . Find more EQRx email formats with LeadIQ. How much funding has EQRx raised to date?
As of December 2023, EQRx has raised $1.2B in funding. The last funding round occurred on Dec 17, 2021 for $1.2B.When was EQRx founded?
EQRx was founded in 2019.
Company Overview
- Headquarters
- Cambridge, MA US
- Website
- revmed.com
- SIC Code
- 8733 - Noncommercial Research Organizations
- Stock Symbol
- EQRX
- NAICS Code
- 541714 - Research and Development in Biotechnology (except Nanobiotechnology)
- Founded
- 2019
- Employees
- 201-500
Media & News
Funding & Financials
- $1.2B
EQRx has raised a total of $1.2B of funding over 3 rounds. Their latest funding round was raised on Dec 17, 2021 in the amount of $1.2B.
- $10M$50M
EQRx's revenue is in the range of $10M$50M
Funding & Financials
- $1.2B
EQRx has raised a total of $1.2B of funding over 3 rounds. Their latest funding round was raised on Dec 17, 2021 in the amount of $1.2B.
- $10M$50M
EQRx's revenue is in the range of $10M$50M
Company Leadership
M. N.Chief Executive Officer- C. C.Chief Compliance And Risk Officer
- J. R.Chief Financial Officer
K. R.Chief Customer Officer
R. A.Chief People Officer
Employee Directory
- K. R.Chief Customer Officer
- L. G.Founder And Partner
- P. M.Talent Acquistion Partner
- R. F.Co-Founder And Cxo
- R. A.Chief People Officer
1-888-653-2347 
support@leadiq.com © LeadIQ, Inc. All rights reserved.
